Population Pharmacokinetics and Exposure-Response Relationships of Belimumab Following Subcutaneous Administration in Subjects with Systemic Lupus Erythematosus

被引:0
|
作者
Struemper, Herbert [1 ]
Thapar, Mita [2 ]
Gordon, David [3 ]
Roth, David [3 ]
机构
[1] PAREXEL, Quantitat Clin Dev, Durham, NC USA
[2] ICON, Marlow, Bucks, England
[3] GlaxoSmithKline, Collegeville, PA USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
T-17
引用
收藏
页码:S56 / S56
页数:1
相关论文
共 50 条
  • [31] EVALUATION OF THE EXPERIENCE, SATISFACTION AND OUTCOMES OF AN AUTOINJECTOR FOR SELF-ADMINISTRATION OF SUBCUTANEOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Dashiell-Aje, E.
    Harding, G.
    Pascoe, K.
    DeVries, J.
    Berry, P.
    Ramachandran, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1050 - 1051
  • [32] Population Pharmacokinetics, Efficacy Exposure-Response Analysis
    Chan, Phyllis
    Yu, Jiajie
    Chinn, Leslie
    Prohn, Marita
    Huisman, Jan
    Matzuka, Brett
    Hanley, William
    Tuckwell, Katie
    Quartino, Angelica
    PHARMACEUTICAL RESEARCH, 2020, 37 (02)
  • [33] Favorable Response to Belimumab in Childhood-Onset Systemic Lupus Erythematosus
    Hui-Yuen, Joyce S.
    Bermudez-Santiago, Liza Mariel
    Isgro, Josephine
    Eichenfield, Andrew H.
    Starr, Amy J.
    Imundo, Lisa F.
    Askanase, Anca
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S37 - S37
  • [34] Favorable Response to Belimumab in Pediatric-Onset Systemic Lupus Erythematosus
    Hui-Yuen, Joyce
    Taylor, Jennifer
    Li, Xiao Qing
    Bermudez, Liza Mariel
    Isgro, Josephine
    Eichenfield, Andrew H.
    Starr, Amy J.
    Imundo, Lisa F.
    Buyon, Jill P.
    Furie, Richard
    Kamen, Diane L.
    Manzi, Susan
    Petri, Michelle
    Ramsey-Goldman, Rosalind
    van Vollenhoven, Ronald
    Wallace, Daniel J.
    Askanase, Anca
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S293 - S293
  • [35] Everolimus in pulmonary transplantation: Pharmacokinetics and exposure-response relationships
    Kovarik, JM
    Snell, GI
    Valentine, V
    Aris, R
    Chan, CKN
    Schmidli, H
    Pirron, U
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (04): : 440 - 446
  • [36] Exposure-response analysis for selection of optimal dosage regimen of anifrolumab in patients with systemic lupus erythematosus
    Chia, Yen Lin
    Santiago, Linda
    Wang, Bing
    Kuruvilla, Denison
    Wang, Shiliang
    Tummala, Raj
    Roskos, Lorin
    RHEUMATOLOGY, 2021, 60 (12) : 5854 - 5862
  • [37] Exposure to belimumab in the first trimester of pregnancy in a young woman with systemic lupus erythematosus
    Gandino, Ignacio Javier
    Lutgen, Sophia
    Basta, Maria Cristina
    Munoz, Sebastian Andres
    REUMATOLOGIA CLINICA, 2021, 17 (07): : 428 - 429
  • [38] Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure-Response
    Balevic, Stephen J.
    Niu, Jing
    Chen, Jianmeng
    Green, Dionna
    McMahon, Ann
    Hornik, Christoph P.
    Schanberg, Laura E.
    Glaser, Rachel
    Gonzalez, Daniel
    Burckart, Gilbert J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (01): : 105 - 118
  • [39] POPULATION PHARMACOKINETICS OF ATACICEPT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Papasouliotis, O.
    Yalkinoglu, Oe
    Golob, M.
    Willen, D.
    Girard, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1077 - 1077
  • [40] Exposure-Response Analysis for Selection of Optimal Dosage Regimen of Anifrolumab in Patients with Systemic Lupus Erythematosus
    Santiago, L.
    Wang, B.
    Brohawn, P.
    Wang, L.
    Illei, G.
    Roskos, L.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68